ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Polio Vaccine Market Research Report 2026
Published Date: 2026-02-06
|
Report Code: QYRE-Auto-18B4237
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Polio Vaccine Market Research Report 2021
BUY CHAPTERS

Global Polio Vaccine Market Research Report 2026

Code: QYRE-Auto-18B4237
Report
2026-02-06
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
GSK
Bibcol
Serum Institute
Tiantan biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Polio Vaccine Market Size

The global Polio Vaccine market was valued at US$ 799 million in 2025 and is anticipated to reach US$ 1062 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Polio Vaccine Market

Polio Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Polio Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.
This report delivers a comprehensive overview of the global Polio Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Polio Vaccine. The Polio Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Polio Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Polio Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Polio Vaccine Market Report

Report Metric Details
Report Name Polio Vaccine Market
Accounted market size in 2025 US$ 799 million
Forecasted market size in 2032 US$ 1062 million
CAGR 4.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Inactivated Polio Vaccine (IPV)
  • Oral Polio Vaccine (OPV)
by Application
  • Public
  • Private
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Polio Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Polio Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Polio Vaccine Market growing?

Ans: The Polio Vaccine Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Polio Vaccine Market size in 2032?

Ans: The Polio Vaccine Market size in 2032 will be US$ 1062 million.

What is the market share of major companies in Polio Vaccine Market?

Ans: Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

Who are the main players in the Polio Vaccine Market report?

Ans: The main players in the Polio Vaccine Market are Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Polio Vaccine Market report?

Ans: The Applications covered in the Polio Vaccine Market report are Public, Private

What are the Type segmentation covered in the Polio Vaccine Market report?

Ans: The Types covered in the Polio Vaccine Market report are Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)

1 Polio Vaccine Market Overview
1.1 Product Definition
1.2 Polio Vaccine by Type
1.2.1 Global Polio Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine by Application
1.3.1 Global Polio Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Public
1.3.3 Private
1.4 Global Polio Vaccine Market Size Estimates and Forecasts
1.4.1 Global Polio Vaccine Revenue 2021–2032
1.4.2 Global Polio Vaccine Sales 2021–2032
1.4.3 Global Polio Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Polio Vaccine Market Competition by Manufacturers
2.1 Global Polio Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Polio Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Polio Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Polio Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Polio Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Polio Vaccine, Date of Entry into the Industry
2.8 Global Polio Vaccine Market Competitive Situation and Trends
2.8.1 Global Polio Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Polio Vaccine Players Market Share by Revenue
2.8.3 Global Polio Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Polio Vaccine Market Scenario by Region
3.1 Global Polio Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Polio Vaccine Sales by Region: 2021–2032
3.2.1 Global Polio Vaccine Sales by Region: 2021–2026
3.2.2 Global Polio Vaccine Sales by Region: 2027–2032
3.3 Global Polio Vaccine Revenue by Region: 2021–2032
3.3.1 Global Polio Vaccine Revenue by Region: 2021–2026
3.3.2 Global Polio Vaccine Revenue by Region: 2027–2032
3.4 North America Polio Vaccine Market Facts & Figures by Country
3.4.1 North America Polio Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Polio Vaccine Sales by Country (2021–2032)
3.4.3 North America Polio Vaccine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Polio Vaccine Market Facts & Figures by Country
3.5.1 Europe Polio Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Polio Vaccine Sales by Country (2021–2032)
3.5.3 Europe Polio Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polio Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Polio Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Polio Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Polio Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Polio Vaccine Market Facts & Figures by Country
3.7.1 Latin America Polio Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Polio Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Polio Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Polio Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Polio Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Polio Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Polio Vaccine Sales by Type (2021–2032)
4.1.1 Global Polio Vaccine Sales by Type (2021–2026)
4.1.2 Global Polio Vaccine Sales by Type (2027–2032)
4.1.3 Global Polio Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Polio Vaccine Revenue by Type (2021–2032)
4.2.1 Global Polio Vaccine Revenue by Type (2021–2026)
4.2.2 Global Polio Vaccine Revenue by Type (2027–2032)
4.2.3 Global Polio Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Polio Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Polio Vaccine Sales by Application (2021–2032)
5.1.1 Global Polio Vaccine Sales by Application (2021–2026)
5.1.2 Global Polio Vaccine Sales by Application (2027–2032)
5.1.3 Global Polio Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Polio Vaccine Revenue by Application (2021–2032)
5.2.1 Global Polio Vaccine Revenue by Application (2021–2026)
5.2.2 Global Polio Vaccine Revenue by Application (2027–2032)
5.2.3 Global Polio Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Polio Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Polio Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Polio Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Company Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bibcol Polio Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Company Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Serum Institute Polio Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Company Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Tiantan Biological Polio Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Company Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 IMBCA Polio Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.7.1 Panacea Biotec Ltd Company Information
6.7.2 Panacea Biotec Ltd Description and Business Overview
6.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Company Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Bio-Med Polio Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Company Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polio Vaccine Industry Chain Analysis
7.2 Polio Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polio Vaccine Production Mode & Process Analysis
7.4 Polio Vaccine Sales and Marketing
7.4.1 Polio Vaccine Sales Channels
7.4.2 Polio Vaccine Distributors
7.5 Polio Vaccine Customer Analysis
8 Polio Vaccine Market Dynamics
8.1 Polio Vaccine Industry Trends
8.2 Polio Vaccine Market Drivers
8.3 Polio Vaccine Market Challenges
8.4 Polio Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
GSK
Bibcol
Serum Institute
Tiantan biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
List of Tables
 Table 1. Global Polio Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Polio Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Polio Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Polio Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Polio Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Polio Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Polio Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Polio Vaccine Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Polio Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Polio Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Polio Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Polio Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Polio Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Polio Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Polio Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Polio Vaccine Sales by Region (K Units), 2021–2026
 Table 18. Global Polio Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Polio Vaccine Sales by Region (K Units), 2027–2032
 Table 20. Global Polio Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Polio Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Polio Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Polio Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Polio Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Polio Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Polio Vaccine Sales by Country (K Units), 2021–2026
 Table 27. North America Polio Vaccine Sales by Country (K Units), 2027–2032
 Table 28. North America Polio Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Polio Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Polio Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Polio Vaccine Sales by Country (K Units), 2021–2026
 Table 32. Europe Polio Vaccine Sales by Country (K Units), 2027–2032
 Table 33. Europe Polio Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Polio Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Polio Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Polio Vaccine Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Polio Vaccine Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Polio Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Polio Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Polio Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Polio Vaccine Sales by Country (K Units), 2021–2026
 Table 42. Latin America Polio Vaccine Sales by Country (K Units), 2027–2032
 Table 43. Latin America Polio Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Polio Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Polio Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Polio Vaccine Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Polio Vaccine Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Polio Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Polio Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Polio Vaccine Sales (K Units) by Type (2021–2026)
 Table 51. Global Polio Vaccine Sales (K Units) by Type (2027–2032)
 Table 52. Global Polio Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Polio Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Polio Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Polio Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Polio Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Polio Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Polio Vaccine Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Polio Vaccine Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Polio Vaccine Sales (K Units) by Application (2021–2026)
 Table 61. Global Polio Vaccine Sales (K Units) by Application (2027–2032)
 Table 62. Global Polio Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Polio Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Polio Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Polio Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Polio Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Polio Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Polio Vaccine Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Polio Vaccine Price (USD/Unit) by Application (2027–2032)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Sanofi Polio Vaccine Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. GSK Polio Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Bibcol Company Information
 Table 81. Bibcol Description and Business Overview
 Table 82. Bibcol Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Bibcol Polio Vaccine Product
 Table 84. Bibcol Recent Developments/Updates
 Table 85. Serum Institute Company Information
 Table 86. Serum Institute Description and Business Overview
 Table 87. Serum Institute Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Serum Institute Polio Vaccine Product
 Table 89. Serum Institute Recent Developments/Updates
 Table 90. Tiantan Biological Company Information
 Table 91. Tiantan Biological Description and Business Overview
 Table 92. Tiantan Biological Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Tiantan Biological Polio Vaccine Product
 Table 94. Tiantan Biological Recent Developments/Updates
 Table 95. IMBCA Company Information
 Table 96. IMBCA Description and Business Overview
 Table 97. IMBCA Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. IMBCA Polio Vaccine Product
 Table 99. IMBCA Recent Developments/Updates
 Table 100. Panacea Biotec Ltd Company Information
 Table 101. Panacea Biotec Ltd Description and Business Overview
 Table 102. Panacea Biotec Ltd Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Panacea Biotec Ltd Polio Vaccine Product
 Table 104. Panacea Biotec Ltd Recent Developments/Updates
 Table 105. Bio-Med Company Information
 Table 106. Bio-Med Description and Business Overview
 Table 107. Bio-Med Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Bio-Med Polio Vaccine Product
 Table 109. Bio-Med Recent Developments/Updates
 Table 110. Halfkin Bio-Pharmaceuticals Company Information
 Table 111. Halfkin Bio-Pharmaceuticals Description and Business Overview
 Table 112. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Halfkin Bio-Pharmaceuticals Polio Vaccine Product
 Table 114. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Polio Vaccine Distributors List
 Table 118. Polio Vaccine Customers List
 Table 119. Polio Vaccine Market Trends
 Table 120. Polio Vaccine Market Drivers
 Table 121. Polio Vaccine Market Challenges
 Table 122. Polio Vaccine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Polio Vaccine
 Figure 2. Global Polio Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Polio Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Inactivated Polio Vaccine (IPV) Product Picture
 Figure 5. Oral Polio Vaccine (OPV) Product Picture
 Figure 6. Global Polio Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Polio Vaccine Market Share by Application: 2025 & 2032
 Figure 8. Public
 Figure 9. Private
 Figure 10. Global Polio Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Polio Vaccine Market Size (US$ Million), 2021–2032
 Figure 12. Global Polio Vaccine Sales (K Units), 2021–2032
 Figure 13. Global Polio Vaccine Average Price (USD/Unit), 2021–2032
 Figure 14. Polio Vaccine Report Years Considered
 Figure 15. Polio Vaccine Sales Share by Manufacturers in 2025
 Figure 16. Global Polio Vaccine Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Polio Vaccine Players: Market Share by Revenue in Polio Vaccine in 2025
 Figure 18. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Polio Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Polio Vaccine Sales Market Share by Country (2021–2032)
 Figure 21. North America Polio Vaccine Revenue Market Share by Country (2021–2032)
 Figure 22. U.S. Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Polio Vaccine Sales Market Share by Country (2021–2032)
 Figure 25. Europe Polio Vaccine Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Polio Vaccine Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Polio Vaccine Revenue Market Share by Region (2021–2032)
 Figure 33. China Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Taiwan Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Philippines Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Polio Vaccine Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Polio Vaccine Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Polio Vaccine Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. U.A.E Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Polio Vaccine by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Polio Vaccine by Type (2021–2032)
 Figure 55. Global Polio Vaccine Price (USD/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Polio Vaccine by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Polio Vaccine by Application (2021–2032)
 Figure 58. Global Polio Vaccine Price (USD/Unit) by Application (2021–2032)
 Figure 59. Polio Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Poliomycetes Vaccine Market Insights Forecast to 2030
Global Poliomyelitis Vaccine Market Research Report 2025
Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polio Vaccination Market Research Report 2025
Inactivated Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inactivated Polio Virus Vaccine Market Research Report 2025
Poliovirus Vaccine Inactivated Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Combined Polio Vaccine Market Research Report 2024
Global Live Attenuated Polio Vaccine Market Research Report 2024
Global Poliomyelitis Vaccine in Dragee Candy Market Research Report 2025
Global Vaccines For Children Market Insights Forecast to 2030
Global Oral Polio Vaccines OPV Market Research Report 2024
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rotavirus Vaccines Market Insights Forecast to 2030
Mono Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sabin Inactivated Polio vaccine sIPV Market Research Report 2025
Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Polio and Rabies Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions